INTERVENE IMMUNE, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2013-01-01
- Employees
- 51
- Market Cap
- -
Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial
Phase 2
Recruiting
- Conditions
- Epigenetic AgingImmunosenescence
- Interventions
- Combination Product: TRIIM TreatmentCombination Product: Active Control
- First Posted Date
- 2020-05-05
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- Intervene Immune, Inc.
- Target Recruit Count
- 85
- Registration Number
- NCT04375657
- Locations
- 🇺🇸
Intervene Immune, Torrance, California, United States
© Copyright 2025. All Rights Reserved by MedPath